Patents by Inventor Olivera Markovic

Olivera Markovic has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150036043
    Abstract: This invention was made to help cytopathology laboratory personnel to use mobile phone camera interchangeably in their everyday practice, when buying more than one model-specific adapter would exceed the cost of reimbursement for such a service and is making mobile-health in clinical pathology obsolete. The interchangeability is reducing the price of using mobile health by the number of applications. This invention is for a small, low-cost device that could simulate movements of a human examiner analyzing cytopathological specimens using the transmitted light microscope.
    Type: Application
    Filed: July 31, 2013
    Publication date: February 5, 2015
    Applicant: BIOSCICON, INC.
    Inventors: Nenad Markovic, Olivera Markovic
  • Publication number: 20040137551
    Abstract: Cervical Acid Phosphatase-Papanicolaou Test Kit (CPK) is an assembly of reagents, controls and instructions for visualization of cervical acid phosphatase on smears or monolayers of cervical specimens, and for performing the CAP-PAP Test (CPT).
    Type: Application
    Filed: January 13, 2003
    Publication date: July 15, 2004
    Inventors: Nenad S. Markovic, Olivera Markovic
  • Patent number: 6143512
    Abstract: The CAP-PAP Test is a double-staining, single-slide microscopic method. An in vitro diagnostic medical device for manual and automatic staining and interpreting of the Pap smear for cervical cancer screening, cervical dysplasia and for follow-up therapy can be developed using this double-staining, single-slide microscopic method. Abnormal cervical cells are labeled with an intracellular acid phosphatase derived pigment (azo-dye) to improve visibility of abnormal cervical cells on conventionally stained Pap smears. The enzyme marker improves human perception and/or sensitivity of automatic instruments when distinguishing cell a abnormality and interpretation of Pap smears. Increased accuracy of CAP-PAP-vs-Pap test is expected to reduce false negative readings of the conventional Pap test. A rapid manual version of the test that is low cost, does not require additional personnel training and is instantly applicable in all cytopathology laboratories is provided.
    Type: Grant
    Filed: June 10, 1999
    Date of Patent: November 7, 2000
    Inventors: Nenad Markovic, Olivera Markovic